Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 15 - Drugs for genital or sexual disorders; Contraceptives
Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
12/2003
12/18/2003WO2003022302A3 USE OF hCG IN CONTROLLED OVARIAN HYPERSTIMULATION
12/18/2003WO2003013536A3 Methods for treatment of cancer using irinotecan based on ugt1a1
12/18/2003WO2003000864A8 Nucleic acid-associated proteins
12/18/2003WO2002100899A3 Medicament for treating tumours and their metastases using a binding molecule against bone-sialoprotein
12/18/2003WO2002058723A3 Chemokines as adjuvants of immune response
12/18/2003WO2002041883A3 As-needed administration of tricyclic and other non-sri antidepressant drugs to treat premature ejaculation
12/18/2003WO2002007678A3 Mu-conopeptides
12/18/2003US20030232849 N-substituted-heteroaryloxy-aryloxy-pyrimidine-2,4,6-trione metalloproteinase inhibitors
12/18/2003US20030232848 Pyrazole compositions
12/18/2003US20030232845 Enzyme hydrolase inhibitors such as 1-ethyl-3,7-dihydro-8-((1 R,2R)-(hydroxycyclopentyl)amino)-3-(2-hydroxyethyl)-7-((3-bromo-4 -methoxyphenyl)methyl)-1H-Purine-2,6-dione, used for physiological effects
12/18/2003US20030232841 Amides such as 5-(2-(4-methylpiperazin-1-yl)-phenyl)-furan-2-carboxylic acid 4-chlorobenzylamide, used as antidepressants and for prophylaxis of headaches
12/18/2003US20030232838 6-phenylpyrrolopyrimidinedione derivatives
12/18/2003US20030232837 17-Beta hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
12/18/2003US20030232824 Non-steroidal progesting
12/18/2003US20030232819 Monoamine transporter inhibitors; used for early diagnosis and treatment of neurological and psychiatric conditions
12/18/2003US20030232814 Novel compounds and their use
12/18/2003US20030232349 Nucleic acid and amino acid sequences of proteases and the use of these sequences in the diagnosis and treatment of gastrointestinal, cardiovascular, autoimmune/inflammatory, cell proliferative, and neurological disorders
12/18/2003US20030232090 Anhydrous antifungal gel comprising polyhydric alcohol(s), a gelling agent and an antifungal azole such as econazole; treating oral and vaginal fungal and bacterial infections
12/18/2003CA2790348A1 Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin f2.alpha. receptor
12/18/2003CA2488719A1 Method of controlled ovarian hyperstimulation and pharmaceutical kit for use in such method
12/18/2003CA2488613A1 Novel formate salt of o-desmethyl-venlafaxine
12/18/2003CA2488403A1 Pharmaceutical formulation
12/18/2003CA2488402A1 Pyrazole-derivatives as p38 kinase inhibitors
12/18/2003CA2488367A1 Antiallergic agents
12/18/2003CA2488356A1 Novel therapeutic use of polypodium extracts
12/18/2003CA2487838A1 Methods and compounds for inhibiting the cytokine or biological activity of mif
12/18/2003CA2483555A1 Gamma lactams as prostaglandin agonists and use thereof
12/17/2003EP1371729A2 Use of ttf3 ligands for the diagnosis and therapy of cancer
12/17/2003EP1371647A2 Pyridine-3-carboxylic acid derivatives and their use as intermediates
12/17/2003EP1371371A1 The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for preventing and treating sexual disorder
12/17/2003EP1371367A1 Use of naaladase inhibitors for the manufacture of a medicament for the treatment of certain diseases
12/17/2003EP1370659A2 Proteins, polynucleotides encoding them and methods of using the same
12/17/2003EP1370588A2 Human monoclonal antibodies to fc alpha receptor (cd89)
12/17/2003EP1370586A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370584A2 Nuclear hormone receptor ligand binding domain
12/17/2003EP1370558A1 Piperazine- and piperidine-derivatives as melanocortin receptor agonists
12/17/2003EP1370556A1 Metalloproteinase inhibitors
12/17/2003EP1370553A2 Rho-kinase inhibitors
12/17/2003EP1370552A2 Rho-kinase inhibitors
12/17/2003EP1370544A1 Nitric oxide donors based on metallic centres
12/17/2003EP1370538A1 Metalloproteinase inhibitors
12/17/2003EP1370537A1 Metalloproteinase inhibitors
12/17/2003EP1370535A1 Metalloproteinase inhibitors
12/17/2003EP1370534A1 Metalloproteinase inhibitors
12/17/2003EP1370530A1 Acylated 1,2,3,4-tetrahydronaphthyl amines and their use as pharmaceutical
12/17/2003EP1370521A1 Formanilide derivatives as beta2-adrenoreceptor agonists
12/17/2003EP1370289A2 Method for producing a vaccine containing autologous antibodies
12/17/2003EP1370279A2 Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies
12/17/2003EP1370277A1 Use of oxytocin for the preparation of a pharmaceutical composition against cancer in situ and cervicitis
12/17/2003EP1370276A2 Medical uses of intercellular communication facilitating compounds
12/17/2003EP1226131B1 Isoxazolecarboxamide derivatives
12/17/2003EP1147121B1 Ketolide antibiotics
12/17/2003CN1462276A Peptide-based compounds
12/17/2003CN1462273A Bicyclic heteroaromatic compounds
12/17/2003CN1462195A Pharmaceutical compositions comprising dendritic cells for immunotherapy of automimmune disease and treatment methods using the same
12/17/2003CN1461652A Pure traditional Chinese medicine prepn. for treating female sterility, and its prepn. method
12/17/2003CN1131230C Tricyclic delta 3-piperidines as alpha 2-antagonists
12/17/2003CN1131064C Medicine for yang-strengthening and kidney-invigorating
12/17/2003CN1131063C Medicine for kidney invigorating and yang strenthening and its preparation method
12/17/2003CN1131057C Chinese medicine fumigant for treating vulval disease and its prepn. method
12/17/2003CN1131037C Application of N-acetyl-Daminoglucose in preparing medicines to prevent and treat sexual disfunction
12/16/2003US6664420 For therapy of hypertension, type 2 insulin-resistant diabetes mellitus, ecalmpsia and preeclampsia
12/16/2003US6664296 Outer envelope including gelatin, and nonaqueous liquid or semi-liquid internal phase containing spermicide, lipophilic agent compatible with rubber latex of condom, gelling agent for lipophile, hydrodispersible agent and bioadhesion agent
12/16/2003US6664247 Pyrazole compounds useful as protein kinase inhibitors
12/16/2003US6664229 Methods for treatment using novel ligands of the neuropeptide receptor HFGAN72
12/16/2003US6664227 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains
12/16/2003US6663865 Tumor necrosis factor antagonists and their use in endometriosis
12/11/2003WO2003102199A1 New gdf-9 and gdf-9b (bmp-15) sequences for altering mammalian ovarian function and ovulation rate
12/11/2003WO2003102168A1 Attenuated listeria spp. and methods for using the same
12/11/2003WO2003102138A2 Elongase genes and uses thereof
12/11/2003WO2003102012A2 New etonogestrel esters
12/11/2003WO2003101994A1 Fused bicyclic aromatic compounds that are useful in treating sexual dysfunction
12/11/2003WO2003101991A1 Xanthine phosphodiesterase v inhibitor polymorphs
12/11/2003WO2003101987A1 3-substituted quinuclidines and their use
12/11/2003WO2003101958A2 Flourinated cyclic amides as dipeptidyl peptidase iv inhibitors
12/11/2003WO2003101539A1 Self-administered contraceptive injection of oily solution
12/11/2003WO2003101461A1 Norethindrone sustained release formulations and methods associated therewith
12/11/2003WO2003101456A1 Use of compounds that stimulate cgmp
12/11/2003WO2003101374A2 Use of new etonogestrel esters
12/11/2003WO2003064463A3 Pluripotency determining factors and uses thereof
12/11/2003WO2003057666A3 Inhibitors of dipeptidyl peptidase iv
12/11/2003WO2003050190A3 Novel combination containing a poloxamer and chondroitin sulphuric acid and/or a glycoprotein and use thereof
12/11/2003WO2003048117A3 Propanolaminomethyltetralines, their preparation and pharmaceutical composition comprising same
12/11/2003WO2003037266A3 Tetra-, penta-, hexa- and heptapeptides having antiangiogenic activity
12/11/2003WO2003027090A3 Bicyclic heterocycles as rxr ligands
12/11/2003WO2003024395A3 Linked biaryl compounds
12/11/2003WO2002087465A3 Compositions and methods of double-targeting virus infections and cancer cells
12/11/2003WO2002085925A3 Melanocortin receptor ligands
12/11/2003US20030229335 Infection therapy; sustained release
12/11/2003US20030229217 Comprises gamma-amino butyric acid (GABA) receptor subunits for treatment of obesity, vision defects, high blood pressure, depression and sexual disorders
12/11/2003US20030229199 Modulator comprising cyclic peptide for use in treatment of cancer, gastrointestinal, inflammatory and nervous system disordrers
12/11/2003US20030229130 Imidazolinylmethyl aralkylsulfonamides
12/11/2003US20030229095 Sexual disorders
12/11/2003US20030229094 Acetamides and benzamides that are useful in treating sexual dysfunction
12/11/2003US20030229083 Compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them
12/11/2003US20030229080 Cardiovascular disorders; sexual disorders
12/11/2003US20030229074 Metabolism; eating disorders; sexual disorders
12/11/2003US20030229072 Cyclic and acyclic amidines and pharmaceutical compositions containing them for use as progesterone receptor binning agents
12/11/2003US20030229057 Continuous sulfatase inhibiting progestogen hormone replacement therapy
12/11/2003US20030229051 Anticancer agents; restenosis; atherosclerosis; skin disorders
1 ... 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 ... 557